SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " treatment " 1,584 found 🔀 AI-powered Shuffle
Scientists reversed memory loss by recharging the brain’s tiny engines
Researchers have shown for the first time that malfunctioning mitochondria — the cell’s energy generators — may directly cause cognitive decline in neurodegenerative diseases. By creating a new tool that temporarily boosts mitochondrial activity in the brain, scientists restored memory performance in mouse models of dementia. The discovery hints that energy failure inside neurons could happen before brain cells die, potentially offering a new target for future Alzheimer’s treatments.
Scientists find hidden brain nutrient deficit that may fuel anxiety
A major analysis of brain scans found that people with anxiety disorders have noticeably lower levels of choline, a nutrient crucial for healthy brain function. The strongest evidence appeared in the prefrontal cortex, the region tied to emotional control and decision-making. Researchers say the discovery is the first clear chemical brain pattern linked to anxiety and could eventually lead to new nutrition-based treatments.
Scientists find hidden brain nutrient deficit that may fuel anxiety
A major analysis of brain scans found that people with anxiety disorders have noticeably lower levels of choline, a nutrient crucial for healthy brain function. The strongest evidence appeared in the prefrontal cortex, the region tied to emotional control and decision-making. Researchers say the discovery is the first clear chemical brain pattern linked to anxiety and could eventually lead to new nutrition-based treatments.
Scientists discover tiny gut particles that may drive aging and chronic disease
A new study suggests microscopic particles from the gut may actively drive inflammation and chronic diseases associated with aging. Remarkably, gut particles from young animals appeared to counter some aging-related damage in older animals, hinting at new possibilities for future treatments.
5 NFL teams didn't get prime-time treatment. The league told the Jets, Raiders, Titans, Dolphins and Cardinals what it thinks of rebuilds
How City of Hope is turning microbiome science into better cancer care
For years, clues pointed to the gut microbiome as a key factor in cancer treatment outcomes. Recent advances in gene sequencing are now clarifying its influence on how patients respond to therapy. At City of Hope, this clarity has catalyzed a more comprehensive model for microbiome science in cancer care. We define the microbiome as […]
Health agency names two schools affected by Berkshire meningitis outbreak
Students from Reading Blue Coat school, and Highdown secondary school and Sixth Form Centre receiving treatment
Health Rounds: Common ADHD medicines help treat cancer-related fatigue
We also report on findings that help explain why the flu can be particularly dangerous for pregnant women and that open the door to potential future treatments.
America's most powerful CEOs don't have much to show from their China trip so far
With red-carpet treatment, selfies and culinary diplomacy, America's richest and most powerful executives - from Tesla's Elon Musk to Nvidia's Jensen Huang - sought to rekindle business ties with China this week at a leadership summit in Beijing.
FDA Blocked Melanoma Drug as Confusion Reigned Under Makary
A third of patients in a clinical trial had tumors shrink while taking a genetically engineered treatment known as RP1.
A smarter helmet for the smallest patients
U-M Health specialists invented a new design for cranial shaping helmets to improve treatment for positional head deformities like plagiocephaly.
MU's Radioisotope Science Center aims for global impact with medical, nuclear innovation
Local, state and federal leaders gathered in Columbia Thursday morning to celebrate state-of-the-art technology in cancer treatment.
ECU Health Medical Center performs its first procedure with Edison® Histotripsy System
New non invasive therapy brings advanced liver tumor treatment closer to home in eastern North Carolina
Hepatitis A
WHO fact sheet on hepatitis A provides key facts and information on transmission, who is at risk, treatment, prevention, immunization and WHO's work in this area.
Accounts in Transit: Rosen Group Picks Up Kustom Entertainment
Rosen Group to bolster media visibility of Kustom Entertainment, a live event production and ticketing technology company....LDPR lands AOR duties for Windjammer Landing Resort & Residences, a Caribbean resort set along the shores of Labrelotte Bay in St. Lucia....Vitamin, a Baltimore-based shop, picks up The Mood Center, a mental health practice specializing in neurotherapy treatments for depression and related conditions.
Strengthening Colorado’s mental-health workforce
By Kyle Brown and Lindsay Gilchrist More than 1.2 million Coloradans live with a diagnosed mental health condition, and in 2023, one in five people seeking care were unable to get the treatment they needed. Overwhelmingly, insurance delays and inadequate provider networks are to blame. A recent study found credentialing for providers takes up to […]
Tiger Woods Signals His Rehab Following DUI Arrest Is Over
In late March, Tiger Woods announced that he would be stepping away from golf - and the public eye - as he sought treatment following his DUI arrest. The 15-time major champion was arrested in Jupiter Island, Florida following a rollover car accident. "I know and understand the seriousness of the ...
Washington AG sues Providence Health and Services alleging illegal mistreatment of pregnant and nursing employees
Joe Rogan podcast appearance tied to rise in demand for alternative cancer treatment
Ivermectin prescriptions spiked among cancer patients after Mel Gibson endorsed antiparasitic drugs on Joe Rogan's podcast, a new JAMA study reports.
What Lil Nas X has to do with a debate over CA mental health law
Supporters of a California mental health law are pointing to singer Lil Nas X as an example of someone who benefited from treatment rather than incarceration.
Groundbreaking Documentary Shines a Light on Postpartum Depression and Perinatal Mental Health Disorders
UNC School of Medicine Executive Dean Samantha Meltzer-Brody, MD, MPH, an international expert in the study and treatment of women’s mood disorders, is among experts featured in a new two-hour film that showcases postpartum depression.
NAMRU Dayton spotlight: Driving Warfighter Health
Lt. Cmdr. Travis Landry's day-to-day responsibilities at NAMRU Dayton are incredibly diverse. On the clinical side, he maintains his operational skills by conducting submarine and physicals and supporting recruiters heading back to the fleet. Notably, he also provides essential medical care for a large, displaced population of Navy personnel in the Dayton area who are far from traditional Navy Military Treatment Facilities (MTFs)—ensuring that these sailors maintain their readiness even while stationed away from the fleet. On the research side, he plays a critical role in human subject safety. Before any study begins, he evaluates participants to ensure they qualify, reviewing their medical histories and medications to guarantee that the research will cause no harm and that the data collected will be accurate.
Californian criminal suspects can trade prison for psychiatric care. Is it working?
Californians accused of crimes can receive mental health treatment rather than prison time. Lawmakers are revamping the rules following reports of violent offenses.
Apreo Health® Adds Independent Director and Strategic Investor to Advance Novel Airway Scaffold for Severe Emphysema
Apreo Health, a clinical-stage medical device company pioneering a tissue-sparing treatment for severe emphysema, today announced the appointment of David Amerson to its Board of Directors and a strategic investment from OSF Ventures, the corporate investment arm of OSF HealthCare. The company also announced it will present new clinical data at the American Thoracic Society (ATS) 2026 International Conference in Orlando, Florida.
NBA Media Called Out For 'Wild' Treatment Of Victor Wembanyama
Victor Wembanyama returned to the spotlight Tuesday night for Game 5 between the Minnesota Timberwolves and San Antonio Spurs. Wembanyama was ejected in the second quarter of Game 4 for throwing an elbow at Timberwolves forward Naz Reid. There's no question his absence played a huge role in San ...
Residential treatment beds in Michigan drop from 1,200 to 398, driving out-of-state care
MICHIGAN., (WPBN/WGTU) -- Michigan children are being sent out of Michigan in order to get the mental health care they need.It's not a new trend. Michigan simpl
First-of-its-kind drainage device helps limit heart failure rehospitalizations
This new catheter-based device for lymphatic drainage showed early potential to be a new treatment option for acute decompensated heart failure.
Scientists reversed biological age in older adults with a 4-week diet change
A four-week diet change was enough to make some older adults appear biologically younger in a new University of Sydney study. Participants who reduced fat intake or shifted toward more plant-based protein showed improvements in key health biomarkers tied to aging. The strongest results came from a lower-fat, higher-carb diet, while people eating closer to their usual diets saw almost no change.
Shortage of beds, staff force Michigan kids out of state for mental health treatment
Michigan kids with serious mental health needs are being sent thousands of miles away from their families to receive proper treatment.
Ketamine therapy could be future of mental health treatment
Ketamine, a common anesthetic, is being used in Maryland to help people with major depression.
New community mental health center planned for Montpelier
Washington County Mental Health Services plans to consolidate services, offering crisis care, intensive treatment and outpatient therapy.
Hantavirus cruise ship: Breaking down health officials' update after Americans return to U.S.
Health officials provided an update from Omaha, Nebraska, after most of the American passengers aboard the hantavirus-stricken cruise ship Hondius arrived there for medical treatment. NBC News medical contributor Dr. Kavita Patel breaks down the key takeaways from the media briefing, including how the patients are being cared for and level of risk to the general population.
The skincare guru Hollywood stars trust for red-carpet skin
High-tech machines and $900 treatments: How Keren Bartov built a skincare empire and global celebrity following.
They sent their teens away for treatment. Then, everything unraveled.
After two suicides led to the sudden closure of Asheville Academy, families who had spent thousands were left scrambling to help their kids in crisis.
New AI tool developed by Stowers Institute and Helmholtz Munich scientists predicts how cells choose their future — helping uncover hidden drivers of development
Scientists at the Stowers Institute for Medical Research and Helmholtz Munich have developed RegVelo, a new AI framework that predicts how cells acquire their identities and identifies the genetic regulators guiding those changes. Published in Cell, the study used zebrafish neural crest development to show RegVelo can uncover early drivers of cell fate, including regulators of pigment cell formation, and then support those predictions experimentally. The researchers also applied the framework across multiple biological systems, suggesting its value extends beyond neural crest cells as a broadly useful tool for studying how cells change over time. The team says the new model could pave the way for future cell therapy treatments.
Learner spotlight: Vivian’s path to rights based mental health advocacy
For Vivian Anyango Aola, mental health is deeply personal. Growing up she witnessed people around her struggling with emotional distress without access to support, understanding or solutions. Those early experiences laid the foundations for her work today as a mental health advocate at St. Daniel Comboni mission in Nairobi, Kenya.“Mental health is about feelings – something we all experience every day,” Vivian explains. “Ensuring people are supported in those feelings is what drives my work.” Creating safe spaces and challenging stigmaIn her role, Vivian works closely with people living with mental health conditions and psychosocial, intellectual and cognitive disabilities. Through dialogue, listening and shared learning, she helps create safe spaces where people feel seen, heard and respected. However, stigma and discrimination remain significant barriers.“Witnessing stigma only strengthens my resolve to fight for inclusion, acceptance and equal treatment for all,” she says. Vivian enrolled in the WHO ‘QualityRights in Mental Health’ online, self-paced course available on the WHO Academy learning platform to strengthen her knowledge and advocacy skills. The six-module course provides the foundation for challenging stigma and discrimination and for promoting person-centred, rights-based approaches in mental health.“The course gave me a new perspective,” she says. “It showed me how to support people in ways that respect autonomy and promote recovery, rather than focusing only on treatment.”The importance of language and cultureSince its launch, more than 141 000 people have enrolled in the course globally, and it is now available in 17 languages on the learning platform – the highest number of languages of any WHO course. For Vivian, accessibility is key to transforming mental health systems. “Language is a bridge between professionals and communities,” she explains. “When mental health resources are available in local languages, they reduce misunderstanding, build trust and encourage people to seek help. It also empowers health workers to deliver care in ways that are culturally sensitive and relevant.”In a global evaluation of the course, which analysed data from over 3000 learners, attitudes toward people with mental health conditions improved by 22.78% overall after completing the course, with even greater shifts in low- and middle-income countries (29.18%) compared to high-income countries (20.58%)[1].“The course equips participants with the essential knowledge and skills to transform mental health into a more rights-based, inclusive and recovery-oriented system,” explains Vivian. “It reinforces that change is possible. When people understand rights, dignity and recovery, the entire system can begin to shift.”Mental Health, Brain Health and Substance Use[1] Breaking stigma, discrimination and promoting rights: global evaluation of the World Health Organization QualityRights e-training on mental health, recovery and community inclusion
Greater weight loss from GLP-1 drugs lowers health complication risk
New research to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Turkey, 12-15 May) shows that, following treatment for obesity or diabetes or both using incretin-based drugs, losing more weight versus less weight, and losing a little weight versus gaining weight, both lead to relatively lower risk of obesity-related conditions.
Science spotlight: AI 'transformative' for cosmetic dermatology
Artificial intelligence (AI) offers significant promise in cosmetic dermatology, but technologies must be used in synergy with human expertise to overcome risks associated with scaled integration. According to a review published in Actas Dermo-Sifiliográficas [1], AI tools have revolutionised skin assessment and the development of personalised treatments in cosmetic dermatology already. And, looking ahead, the researchers said advances are set to further transform the category. “AI has...
Iran releases Nobel Peace Prize winner Narges Mohammadi over health concerns
On Sunday, Mohammadi, winner of the 2023 Nobel Peace Prize, was released on bail and sent to Tehran for medical treatment after 10 days of hospitalization in Zanjan, northern Iran, where she had been serving her sentence.
Iran releases Nobel laureate Narges Mohammadi on bail amid health fears
Iranian Nobel Peace Prize winner Narges Mohammadi has been released on bail and transferred to Tehran for urgent medical treatment after supporters warned she was at risk of dying in prison. The activist,…
FDA Policies: Rigorous Science or Roadblocks?
Readers debate how the Food and Drug Administration should handle treatments for rare diseases.
How a pill approved 25 years ago transformed cancer treatment
When the Food and Drug Administration approved Gleevec to treat a form of leukemia in 2001, it ushered in a new era in cancer care.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
'Full House' star Dave Coulier shares health update amid cancer battle
Dave Coulier revealed he lost 45 pounds and struggled to eat or speak after extensive radiation treatment, while sharing positive news about his cancer prognosis.
Scientists reversed liver aging with young gut bacteria in stunning study
Rebooting the gut microbiome with bacteria from youth may help stop aging-related liver damage and even prevent liver cancer, according to new research in mice. Older mice that received their own preserved youthful microbiome showed less inflammation, reduced DNA damage, and no signs of liver cancer. Researchers also found that the treatment suppressed a cancer-linked gene called MDM2, making older mice biologically resemble younger ones.
Black licorice compound shows promise against inflammatory bowel disease
Researchers have developed a stem cell-based model of the human intestine that may transform how new IBD treatments are discovered. After testing thousands of compounds, they identified glycyrrhizin — a natural substance found in black licorice — as a promising anti-inflammatory candidate. In both lab-grown tissue and mice, the compound reduced intestinal damage and cell death linked to IBD.
Poor sleep can cause or worsen mental illness. Which treatments work and what's just hype?
Sleep disorders can cause serious physical and mental health problems. Treatments are aplenty, from gummies, lotions and meditation to apps, sounds, C-PAPs and medications. There are so many medical, over the counter, and influencer-peddled ways to treat sleep problems. What’s hype? What works? And what’s it like when it seems all the remedies are failing?
Scientists found the “holy grail” gene that could one day help humans regrow limbs
Scientists studying axolotls, zebrafish, and mice have uncovered a shared set of genes that may one day help humans regrow lost limbs. By identifying powerful “SP genes” involved in regeneration, researchers discovered that disabling these genes stopped proper bone regrowth in salamanders and mice. They then used a gene therapy inspired by zebrafish biology to partially restore regeneration in mice, marking a major step toward future treatments that could replace damaged limbs with living tissue instead of prosthetics.
Evictions, AI, public transportation bills: CT politics news
Plus: The fate of bills concerning data centers, health care affordability, fertility treatment, Aquarion Water Company and balloons.
FDA announces more recalls due to risk of syringe breaking during treatment
Medline already had to recall millions of syringes due to a significant safety risk. Now, multiple procedure kits that include the devices are also being recalled. The issue has been associated with four serious injuries.
PSMA PET imaging’s proliferation produces uptick in aggressive treatment for prostate cancer
First approved by the FDA in 2021, providers have rapidly adopted this clinical innovation, which offers greater accuracy in detecting prostate cancer.
Delcath Systems Reports First Quarter 2026 Results and Business Highlights
QUEENSBURY, N.Y., May 07, 2026--Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced financial results and business highlights for the first quarter ended March 31, 2026.
If you want to reduce jail overcrowding, start on mental health before the crime happens
Montana keeps investing in mental health facilities for people who have broken the law, in part because of mental illness. Columnist and county attorney Matt Jennings says there's a cheaper, better way to focus on treatment and prevention.
What we’ve learned in Bristol about reproductive freedom
Abortion bans not only create barriers to health care, like we saw with the closure of the Bristol health clinic, but they also change how doctors and nurses approach treatment, guest columnist Cheryl Hanzik writes.
Former Southwest Philly refinery site will become home to nuclear life science facility
The company plans to manufacture a rare, radioactive isotope for use in cancer treatment trials starting in 2029.
Study shows risks for mental health workers in residential treatment facilities
A study published eight years ago found that each year, on average, one mental health worker is a victim of homicide in residential treatment facilities.
Science: A novel gene-therapy approach to ‘functionally cure’ HIV succeeds in some monkeys
Six animals suppressed AIDS virus after one shot of treatment that makes cell-receptor antibody
Cancer treatments can take a toll on body image
The end of cancer treatment doesn't mean the challenges end. Sanford Health helps survivors navigate self-esteem and other concerns.
Busting five myths about mental health with University of Minnesota experts
University of Minnesota experts are setting the record straight with evidence-based research, new treatments and workforce innovations that are changing how mental health conditions are understood and treated.
Wisconsin lab tapped to research psychedelic drug as mental health treatment
A Wisconsin-based medical research lab is one of just three organizations nationwide the federal government has tapped to move forward on research into psychedelic medications.
Impella 5.5 shows promise in certain non-shock, high-risk cardiac surgery patients
New data out of the AATS Annual Meeting identified significant potential for a new treatment strategy.
Mental Health Awareness Month highlights rising needs across western North Carolina
May is Mental Health Awareness Month. Nearly 30 million people across the U.S lack access to affordable, comprehensive mental health and substance treatment.
A better path forward for cancer care - UT Health San Antonio
From the moment of diagnosis, UT Health San Antonio patients are connected to a system designed to expand their treatment possibilities and bring the full strength of medicine and research to their care. Specialized programs focus on common and rare cancers, which allows for more personalized treatment approaches. For those at increased risk, services such as cancer genetics counseling and risk-reduction clinics offer early insight and prevention strategies.
Woman in cancer remission without treatment in highly unusual case
A biopsy of a woman's cancer seems to have triggered an immune response against the tumour, putting her into remission
Dolly Parton cancels Las Vegas residency and gives health update
“The good news is I’m responding really well to meds and treatments and I’m improving every day,” the 80-year-old star said.
Country music legend cancels concerts, admits feeling ‘swimmy headed’
The Rock and Roll Hall of Famer said she's responding well to medicine and treatment.
Dolly Parton cancels Las Vegas residency and steps back from performing amid health concerns
Dolly Parton did not disclose the specific health condition that she is receiving treatment for, but said that she would be too dizzy to take the stage for her residency this year.
Dolly Parton cancels Las Vegas residency over health issues: ‘I’ve still got some healing to do’
The 80-year-old singer will not be performing rescheduled dates in September but assured fans she is receiving treatment and ‘improving every day’
Dolly Parton Cancels Las Vegas Residency Due to Health, Shares Update
"I'm responding really well to meds and treatments, and I'm improving everyday," the Grammy winner said, while noting that "it's gonna take me a little while before I'm up to stage-performance level."
Dolly Parton gives health update: ‘Good news and a little bad news’
KNOXVILLE, Tenn. (WATE) — Dolly Parton gave a health update Monday afternoon sharing “good news and a little bad news.” Parton said she was responding well to medicine and treatments an…
Baptist hospital
PENSACOLA, Fla. -- When a patient’s heart and lungs are too weak to function, a specialized rescue treatment called ECMO can provide short- to long-term support
Trump Backed Forced Treatment for Homeless People. Utah Shows the Challenges.
State lawmakers declined to back a Trump-inspired plan to move 1,300 homeless people to a campus on the edge of Salt Lake City, but supporters are trying to keep the plan’s spirit alive.
How Republicans came to embrace psychedelic drugs
After decades of backing a “war on drugs,” the GOP has warmed to psychedelics for mental health treatment as high-profile backers and veterans tout the drugs.
Global Health & WASH: May 2026 Funding Opportunities (14 new opportunities!)
The May update for Global Health & WASH brings new calls that cluster around three distinct shifts: LMIC research leadership moving from funder encouragement into a hard eligibility constraint, pharmaceutical and corporate-linked funders running structurally independent education and use-inspired research portfolios at substantial scale, and AI adoption shifting decisively from speculative tool to operational capability across health and WASH systems alike. In LMIC Research Leadership as Eligibility, Not Encouragement, Wellcome anchors the dominant signal of the month with three separate major calls that all require or strongly center LMIC leadership in their basic eligibility architecture. Wellcome’s ESIC Hubs (£1.5-£1.9M per hub over 3-5 years) explicitly requires an LMIC-based lead applicant, treating Global South leadership as a design constraint rather than a participation goal. Wellcome’s Infectious Disease Clinical Trial Development Award funds transdisciplinary teams whose lead must be a mid-career or established researcher based at an organization in Africa, South Asia, or Southeast Asia. Wellcome’s larger Infectious Disease Clinical Trial Award (£1M-£8M for optimizing licensed interventions) requires the administering organization to be in eligible LMIC regions and at least 50% of applicants based there. Around Wellcome, the same pattern shows up at smaller scale and across funders: CHINNOVA channels $1M into West and Central African research institutions for climate-health work; IBRO’s Neuroscience Training Grants explicitly tier ceilings by region of residence with Africa receiving the highest amount ($5,000); IHME’s GBD Emerging Researcher Award reserves at least one of its two annual awards for an LMIC researcher; Sidaction’s HIV Cure call funds research teams across France, the Netherlands, and eligible African countries with a minimum two-country collaboration requirement. Taken together, these calls signal a meaningful shift in how research equity is being operationalized — not as encouragement language at the bottom of a call, but as a structural feature of who can lead, where the work must be administered, and what proportion of the team must be regionally rooted. In Pharma-Funded Independent Medical Education and Use-Inspired Research, the lineup this month is unusually deep. Pfizer alone runs four parallel calls under independent education and quality improvement frameworks: a Migraine and Women’s Health RFP (200K x 2-year, $500K pool), Migraine IME ($200K, $1M pool), JAK Inhibitor evidence-based education ($100K), and Maternal Vaccination HCP Education in Saudi Arabia ($75K), plus a separate Pediatric Pneumococcal Surveillance research call in Saudi Arabia ($400K per project). Novo Nordisk Foundation runs four parallel calls of its own at substantial scale: Infectious Diseases Catalyst Grants (DKK 60M pool, up to DKK 7M collaborative), Non-Diabetic Endocrinology Collaborative Grants (DKK 53M pool, DKK 5-10M per project), Pioneer Innovator Grant Health (DKK 1.1M), and Distinguished Innovator Grant Health (DKK 6.8M). LEO Foundation deploys DKK 2-4M per project for dermatology research excellence. Pfizer’s framing across calls deliberately separates the funding from product promotion, emphasizing measurable practice-relevant change and structural distance between scientific outputs and commercial activity. Novo Nordisk’s “use-inspired” hard filter pushes researchers toward a credible translation pathway from mechanism to deployable tool. The pattern: industry-aligned funders are running structurally independent portfolios at meaningful $ that fund implementation evidence, not promotion. In AI as Operational Capability, Not Speculation, several calls this month explicitly treat AI adoption as a near-term operational question with real evidence and governance requirements, rather than a speculative trend to be watched. Wellcome’s ESIC Hubs frames AI as “the accelerator” for evidence synthesis, asking hubs to translate technical innovation into adoption-ready workflows that can match real-world policy timelines. UNICEF Venture Fund’s new Climate Tech for Children’s Health call funds for-profit startups deploying AI, machine learning, and blockchain in low-resource environments, with a strict requirement that solutions must already have a working prototype with promising pilot results. The Water Research Foundation has launched two simultaneous AI calls treating reproducibility, cybersecurity guardrails, and human-in-the-loop deployments as core design constraints rather than nice-to-haves: one on GenAI and Agentic AI in water utilities ($200K), one on alternatives to water shutoffs that explicitly screens for implementation economics evidence. Nordic Innovation’s quantum technology call (NOK 4.5M) extends the same logic into life science and healthcare, demanding consortium-stage projects mature enough to test with real users. TEF-Health offers €300K in subsidized testing infrastructure for European healthcare AI and robotics SMEs. The pattern: funders are converting AI pilots into playbooks, requiring transfer evidence and risk controls before AI can move from experimentation to sector-wide operational practice. For LMIC-based researchers in infectious disease or evidence synthesis, the three Wellcome calls together represent the deepest concentration of LMIC-led research capital in recent memory — pair the Infectious Disease Clinical Trial Development Award (£200K, deadline May 19) as a strategic pipeline feeder into the larger Infectious Disease Clinical Trial Award (£1-£8M, deadline June 2), since the development award functions explicitly as a track into the larger trial scheme. For Nordic researchers, the four Novo Nordisk Foundation calls plus LEO Foundation and Nordic Innovation Quantum represent ~$30M in regional research capital this cycle, all with deadlines clustered in May-August. For WASH practitioners, the three Water Research Foundation calls together (each up to $200K) are a cluster worth reading across — one on AI deployment, one on shutoff alternatives, one rewarding applied innovation — and the strongest applicants will articulate how their work bridges utility operations to policy-relevant evidence. For US-based clinical researchers and educators, the four Pfizer calls plus the APF Portfolio’s 80+ programs form an unusually accessible recurring pipeline; APF’s prohibition on indirect costs is a meaningful structural feature for early-career applicants whose institutions might otherwise absorb significant overhead. Snapshot of New Opportunities Total Estimated Funding Pool: $100 Million+ USD The grants are organized into three categories: Open Calls: Current grant and opportunities with a deadline. Grants are listed by closing date. 39 open opportunities- 14 new! Rolling Applications: current grant and opportunities with rolling applications (but it’s still best to submit as early as possible). 14 rolling opportunities- 1 new opportunity! Long term planning: Grants that have closed their current rounds, but are expected to open new windows. 4 long term opportunities! A quick tip for returning readers: if you want to jump straight to the newest additions, use CTRL F to search for “New!” and navigate quickly to the latest funding opportunities This post is for paid subscribers. This helps support the time and effort it takes to curate and organize these opportunities. Subscribe To keep this accessible to everyone who needs it, we’re happy to offer pay what you can rates. You can find more details here. Open Calls: Migraine Competitive Grant Program: Migraine and Women’s Health (Quality Improvement and/or Research RFP), Pfizer.*Closing soon!* Pfizer, in collaboration with the American Headache Society, is seeking independent quality improvement and research projects that close persistent gaps in migraine care for women across the United States. The funding logic centers on measurable, practice-relevant change: proposals should generate actionable evidence, tools, or system improvements that can be shared and used widely, not just within a single site. Priority areas span menstrual migraine and screening in women’s health settings, the role of hormonal fluctuations across the lifespan, sex-specific risk factors, comorbidities and quality-of-life burden, and disparities in outcomes by race, ethnicity, and socioeconomic status. The call is structured as a two-step competitive process with an initial Letter of Intent, with the strongest concepts expected to translate scientific insight into implementable improvements in diagnosis, management, and equity. Geographies: United States. Who can apply: U.S.-based organizations (not individuals), including professional schools, healthcare institutions, professional organizations, and other entities focused on healthcare improvement. Funding amount: Up to USD $200,000 total over 2 years; total pool USD $500,000. Targeted Sectors / SDGs: Health; Focus areas: migraine, women’s health, quality improvement, clinical research, menstrual migraine, health disparities. Deadline: LOI: May 5, 2026; Full proposal (by invitation): August 28, 2026. Learn more and apply here. This RFP rewards “shareable impact”: the most competitive submissions will pair rigorous methods with a clear plan for system uptake and dissemination beyond the originating institution. ReSSARC: Strengthening the Health Sector and Food Security in the Central African Republic (AID 013381/01/0) Call for Proposals, Italian Agency for Development Cooperation (AICS). *Closing soon!* AICS is seeking a limited set of high-capacity humanitarian partners to deliver an integrated package that stabilizes essential health services while reducing acute malnutrition and strengthening food security resilience in priority areas of the Central African Republic. The funder’s logic is explicitly nexus-based: proposals should meet urgent, life-saving needs while reinforcing local systems, coordination mechanisms, and community-level capacity so results persist beyond the emergency window. AICS emphasizes inclusion and protection outcomes, expecting gender-sensitive design and explicit measures for groups facing compounded vulnerability, including women, children under five, internally displaced people, and people with disabilities. The call also signals a localization pathway, encouraging stronger collaboration with national NGOs and balanced partnerships, alongside clear coordination with existing cluster and humanitarian actors to minimize duplication and improve coverage. Geographies: Central African Republic (Bangui, Ombella-Mpoko, Ouham, Ouham-Pende, Lim-Pende, Lobaye). Who can apply: Non-profit organizations registered with AICS, plus eligible non-profits without an office in Italy that have a pre-existing collaboration agreement with an AICS-listed organization. Funding amount: Total pool EUR €1,800,000; max EUR €800,000 (single applicant) or EUR €1,000,000 (ATS). Targeted Sectors / SDGs: Health; Focus areas: malnutrition prevention and treatment, maternal and child health, community health services, food security and resilience, localization partnerships Deadline: May 5, 2026. Learn more and apply here. This call is structured to reward partners who can link frontline service delivery to system durability and localization, not just short-term coverage gains. Contracts for Innovation in drug and alcohol addiction healthcare, Innovate UK. *Closing soon!* Innovate UK, on behalf of the Office for Life Sciences Addiction Healthcare Goals program, is procuring R&D to accelerate innovations that can improve treatment outcomes, strengthen recovery, and reduce harm and deaths linked to drug and alcohol addiction. The competition is positioned as a market-facing readiness push: selected projects are expected to advance solutions toward later-stage validation, generate evidence of user acceptability and UK market fit, and map credible routes through regulatory and certification requirements. Innovate UK signals a preference for innovations that can be field-tested in relevant UK settings and progressed to TRL 6 or 7, with practical plans for commercialization after contract completion. This structure favors applicants that can execute most work in-house, co-develop with service providers and people with lived experience, and translate technical progress into deployable tools for addiction healthcare delivery. Geographies: United Kingdom. Who can apply: Single organizations of any size (including EU, EEA, or international) leading delivery, with most work and key deliverables carried out in the UK; subcontractors for specialist skills only. Funding amount: GBP £200,000–1.5 million per project (inclusive of VAT); Total pool: GBP £20 million (across two strands). Targeted Sectors / SDGs: Health; Focus areas: Mental Health, Health Systems Strengthening, Research & Development, Technology Access. Deadline: May 6, 2026 (11:00am). Learn more and apply here. This call uses procurement to pull near-market addiction innovations toward operational proof and adoption pathways in UK services.
New Treatment at UToledo Health Uses Patient’s Blood Cells to Accelerate Healing
A concentrated solution of the patient's own blood platelets is injected to encourage accelerated healing in a specific area of the body.
Fairview residents surprised by proposed behavioral health treatment center
Wasilla-based True North Recovery plans to expand its services to Anchorage using federal grant money held by the municipality.
Health Ministry changes medical cannabis guidelines, passes responsibility to insurance funds
Cannabis may still be considered in severe cases, such as insomnia or acute distress, but only alongside proven treatments like psychotherapy and under close supervision.
3 Medical Routines That Older People May Not Need
Some screenings and treatments no longer make sense for patients as they age. Researchers have just added a few more to the list.
Scientists sound alarm as dangerous amoebas spread globally
Free-living amoebae are emerging as a global health concern, fueled by warming temperatures and outdated water systems. While many are harmless, some can cause deadly infections and even protect other dangerous microbes. Their ability to survive heat and disinfectants makes them especially hard to control. Scientists say improved surveillance and water treatment are urgently needed.
Surgery still outperforms GLP-1 drugs in terms of heart health
Both treatment options are effective, but metabolic and bariatric surgery was linked to more significant cardiovascular risk reductions than GLP-1 medications.
The Next Alzheimer’s Breakthrough Will Take More Than Just Science
At WIRED Health, pioneering Alzheimer's researcher John Hardy outlined the stakes—and next steps—of where treatment is headed next.
I'm trying to delay menopause to 60. Here's how I'm doing it
Kayla Barnes-Lentz is using diet, lifestyle changes, and experimental treatments to slow ovarian aging and push menopause as late as possible.
New treatment cuts bad cholesterol by nearly 50% without statins
A new breakthrough could change how high cholesterol is treated, offering a powerful alternative to traditional drugs. Researchers have developed tiny DNA-based molecules that shut down PCSK9—a key protein that keeps “bad” LDL cholesterol circulating in the blood. By blocking this protein, cells can absorb more cholesterol instead of letting it build up in arteries, dramatically lowering levels linked to heart disease.
Medicare, Medicaid privileges officially end at Laurel Ridge Treatment Center
As of Thursday morning, Laurel Ridge officially was cut off from Medicare and Medicaid benefits. Patients using those forms of coverage will now have to seek treatment elsewhere.
Triumph Over Tremors
UCLA Health and the Be Still Foundation host the Triumph Over Tremors Pickleball Tournament Series May 16th — uniting communities nationwide to support those with Essential Tremor and Parkinson’s, with proceeds funding awareness, education, support, and access to life-changing treatments.
Michigan's Dusty May provides health updates for returner, newcomers on mend
L.J. Cason (ACL), Lincoln Cosby (ACL) and Jalen Reed (Achilles) are all coming off major injuries, and Marcus Moller is receiving cancer treatment.
Scientists restore memory by blocking a single Alzheimer’s protein
Researchers have identified a new potential weapon against Alzheimer’s: blocking a protein called PTP1B. In mice, this approach boosted memory and helped brain immune cells clear harmful plaque buildup. Since PTP1B is also linked to diabetes and obesity—both risk factors for Alzheimer’s—it could offer a broader treatment strategy.
Scientists reveal the best exercise for knee arthritis pain relief
A major review of 217 trials shows that aerobic exercise is the most effective option for managing knee osteoarthritis. Activities like walking, cycling, and swimming outperformed other exercise types in reducing pain and improving movement. While alternatives like strength training and mind-body exercises help, they are best used alongside aerobic workouts. The findings also confirm that exercise is a safe and essential part of treatment.
Simple treatment tweak drastically reduces blood loss from severe cuts
A procedure that could be done in half an hour, and prepared ahead of time, could seriously reduce blood loss from severe wounds, such as during surgery
Australia becomes the 30th country to eliminate trachoma as a public health problem
The World Health Organization (WHO) has validated Australia for eliminating trachoma as a public health problem, marking a significant milestone in the health of indigenous peoples and in global efforts to combat neglected tropical diseases (NTDs). Trachoma, the world’s leading infectious cause of blindness, no longer represents a public health problem in the country.Australia is among a growing number of countries that have successfully eliminated trachoma, contributing to global progress towards the targets set out in the WHO road map for NTDs 2021–2030.Trachoma is caused by the bacterium Chlamydia trachomatis and spreads through close contact with infected individuals, contaminated surfaces, and flies that carry eye and nose discharge. Repeated infections can lead to scarring of the eyelids, turning eyelashes inward, and ultimately causing blindness if untreated.“WHO congratulates Australia on this important achievement,” said Dr Tedros Adhanom Ghebreyesus, WHO Director-General. “This success reflects sustained commitment, strong partnerships, and a focus on reaching populations most affected by health inequities. It brings us closer to a world free from the suffering caused by trachoma.”Australia’s journey to eliminationAustralia’s achievement reflects decades of targeted public health action, particularly in remote Aboriginal and Torres Strait Islander communities, where trachoma persisted despite its earlier disappearance from the rest of the country.National efforts intensified with the establishment of the National Trachoma Management Programme in 2006, which implemented the WHO-recommended SAFE strategy: surgery for trichiasis, antibiotics to treat infection, promotion of facial cleanliness, and environmental improvement. Regular screening of all communities classified as at-risk of trachoma by teams of qualified health workers formed an important part of the Programme. Interventions were delivered through coordinated partnerships between federal and state governments, Aboriginal community-controlled health services, and local communities.Over time, sustained screening, treatment, and prevention activities, including improvements in housing, water, sanitation and hygiene, led to a steady decline in trachoma prevalence. Australia’s approach included adaptations to reflect its context, such as targeted treatment based on community-level data rather than mass drug administration, and strong integration with environmental health programmes.“Elimination of trachoma is a win for the eye health of communities across Australia, particularly those whose lives have been impacted by a disease that is entirely preventable,” said Mark Butler, Minister for Health and Ageing, Australia. “This major milestone is thanks to Aboriginal and Torres Strait Islander leadership, community commitment and sustained investment over many decades.“The lessons from this work will inform how we approach other preventable health conditions in remote and regional Australia. Aboriginal Community Controlled Health Organisations and local health workers have been central to this success, delivering culturally safe care and community-led solutions.”“This recognition from the World Health Organization reflects decades of work led by Aboriginal Community Controlled Health Organisations, alongside local health workers in remote First Nations communities,” said Malarndirri McCarthy, Minister for Indigenous Australians. “Their work has been critical to eliminating trachoma as a public health problem in Australia.”Advancing global efforts against neglected tropical diseases (NTDs)Trachoma is one of 21 diseases and disease groups that are regarded by WHO as NTDs. Together, NTDs affect more than 1 billion people worldwide, primarily in underserved populations with limited access to essential services such as clean water, sanitation, and health care.Australia’s elimination of trachoma as a public health problem highlights the importance of sustained political commitment and cross-sectoral collaboration in addressing the underlying determinants of health. It also underscores the feasibility of eliminating trachoma even in geographically challenging settings.In addition to trachoma, Australia has several endemic NTDs, including Buruli ulcer, leprosy and scabies. Validation of elimination of trachoma as a public health problem marks the first time that WHO has confirmed the elimination of an NTD in Australia, which becomes the 63rd country globally and 16th in the Western Pacific Region to have eliminated at least one NTD.“Tackling neglected tropical diseases in the Western Pacific Region has long been a challenge for countries across the socioeconomic spectrum, given the complexities in reaching the most vulnerable communities, including in remote areas,” said Dr Saia Ma’u Piukala, WHO Regional Director for the Western Pacific. “As a doctor from Tonga, I’ve experienced these challenges for myself. But I also know that with strategic commitment underpinned by optimal resources and partnerships in health, success is possible as other countries in our region have also demonstrated. I commend Australia on eliminating trachoma as a public health problem and urge all involved to remain vigilant to ensure this status is maintained.”WHO continues to support countries working to eliminate trachoma and other NTDs, ensuring that progress reaches those most in need and that gains are sustained through strong surveillance, appropriately integrated into national health systems, and mainstreamed within the wider health sector and beyond.Editor’s notesNeglected tropical diseases and trachoma elimination effortsNeglected tropical diseases are associated with devastating health, social and economic consequences. Their burden is mainly felt among impoverished communities in tropical areas.Public health targets for the control, elimination and eradication of these conditions were set in the road map for neglected tropical diseases 2021–2030 (https://www.who.int/publications/i/item/9789240010352).In 1996, WHO launched the WHO Alliance for the Global Elimination of Trachoma by 2020 (GET2020), creating a network of governments, non-governmental organizations and academic institutions dedicated to the fight against trachoma. WHO continues to support endemic countries to accelerate progress towards the global target of eliminating trachoma as a public health problem worldwide; 2030 is the new target date.Elimination of trachoma as a public health problem is defined as: (i) a prevalence of trachomatous trichiasis (TT) “unknown to the health system” of < 0.2% in ≥15-year-olds; and (ii) a prevalence of trachomatous inflammation—follicular (TF) in children aged 1–9 years of < 5%, in each formerly endemic district, plus (iii) the existence of a system to identify and manage incident cases of TT.Other countries validated by WHO as having eliminated trachoma as a public health problem are: Algeria, Benin, Burundi, Cambodia, China, Egypt, Fiji, Gambia, Ghana, India, Iraq, Islamic Republic of Iran, Lao People’s Democratic Republic, Libya, Malawi, Mali, Mauritania, Mexico, Morocco, Myanmar, Nepal, Oman, Pakistan, Papua New Guinea, Saudi Arabia, Senegal, Togo, Vanuatu and Viet Nam.
Impending layoffs at Laurel Ridge Treatment Center spark concerns about mental health care
Laurel Ridge Treatment Center announced that 648 employees would be laid off, effective June 26. Some are worried about the impact it will have on the availability of mental health treatment in San Antonio.
FDA warns public about vascular device after 3 deaths
The FDA is still investigating this issue. For now, the agency recommends considering alternative treatment options when possible.
“Jurassic Park” star Sam Neill reveals health update after cancer treatment stopped working: 'I was on the way out'
The Australian star, 78, was "at a loss" amid treatment.
MIT scientists turn chaotic laser light into powerful brain imaging tool
Scientists at MIT discovered that chaotic laser light can spontaneously form a highly focused beam instead of scattering—if the conditions are just right. This “pencil beam” enabled them to image the blood-brain barrier in 3D at speeds 25 times faster than existing techniques. The method also lets researchers watch how drugs move into brain cells in real time. It could dramatically accelerate the development of treatments for neurological diseases.
How science is finally making real progress in treating allergies
After decades of limited options, allergy care is may no longer a one-size-fits-all treatment approach.